Gold standard investigation for diagnosis of insulinoma –
**Core Concept**
The diagnosis of insulinoma, a type of pancreatic tumor that produces excess insulin, relies on demonstrating inappropriate insulin secretion. **Insulinomas** are usually small, solitary, and benign. The gold standard investigation should accurately localize the tumor and confirm its nature.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general approach. The diagnosis typically involves a combination of clinical presentation, biochemical tests (like fasting test), and imaging studies. Among imaging studies, **endoscopic ultrasonography** and **68Ga-DOTATATE PET/CT** are highly sensitive for localizing insulinomas due to their ability to detect small tumors and their metabolic activity.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, generally, any option that does not involve precise localization and metabolic assessment of the tumor would be incorrect.
**Option B:** Similarly, an option lacking in sensitivity for small tumors or not specifically targeting insulinoma characteristics would be wrong.
**Option C:** An option that is more invasive or less accurate than the gold standard would also be incorrect.
**Option D:** Any option that does not align with current best practices for insulinoma diagnosis would be incorrect.
**Clinical Pearl / High-Yield Fact**
A key point in diagnosing insulinoma is the **Whipple's triad**: symptoms known or likely to be caused by hypoglycemia, a low plasma glucose measured at the time of the symptoms, and relief of symptoms when the glucose is raised to normal.
**Correct Answer:** Not provided, however, typically **Correct Answer: D. 68Ga-DOTATATE PET/CT or another accurate localization method**.